Drug Recognition Expert Tutorials for Defence Lawyers

May 4, 2018 recorded version still available with materials 9 a.m. to 12 noon eastern time
June 8, 2018 recorded version still available with materials 9 a.m. to 12 noon eastern time
The morning programs were recorded , so if you missed the sessions, you can connect on-demand.

Ben Joseph, MD, Joel Mayer, Ph.D., and David Rosenbloom, Pharm. D.


May 4, 2018 at 9:00 AM to 12:00 noon eastern time

Ben Joseph, Joel Mayer, and David Rosenbloom review the twelve steps that form the DRE procedure.  Ben Joseph  worked as a forensic toxicologist for the Centre of Forensic Sciences (CFS) for over a decade.  David Rosenbloom is a professor in the Department of Medicine at McMaster University. He discusses the twelve steps' application to marijuana from a pharmacological and neurological perspective. Joel Mayer has extensive experience in drug toxicology.

An annotated recording of the May 4 morning program is now available to defence lawyer registrants, together with an extensive database of materials.

Nathan Baker, Ontario lawyer and David Rosenbloom, Pharm. D.


June 8, 2018 at 9:00 AM to 12:00 noon eastern time

Drug impaired driving in Canada is a growing area, especially with the legalization of cannabis on the horizon. Understanding the testing used, both chemical and physical, as well as the legal components in constructing a defence for these cases will be critical for practitioners.  Seeing a DRE evaluation, what the officers are looking for, what their qualifications mean and how they apply this to the drug categorization matrix will all be reviewed.  Issues with burdens of proof, charter considerations and common concerns noted by the judiciary are all to be discussed in order to provide a foundation for proper defence.

An unedited recording of the June 8 morning program is now available to defence lawyer registrants, together with an extensive database of materials.

Participation is limited to defence lawyers, articling students working for defence lawyers, and experts who work with defence lawyers. Online connection by WizIQ.

Fee $100 plus HST per session. Application for online access is attached.

Live sessions from the afternoons are not be available online and were not recorded.

Contacts:

Stephen Biss     905-273-3322

Adel Afzal           416-930-2826

Application for on-demand viewing attached below.

© 2019 Allbiss Lawdata Ltd. All rights reserved. This is not a government web site.

 

 

For more information respecting this database or to report misuse contact: Allbiss Lawdata Ltd., 303-470 Hensall Circle, Mississauga, Ontario, Canada, L5A 3V4, 905-273-3322. The author and the participants make no representation or warranty  whatsoever as to the authenticity and reliability of the information contained herein.  WARNING: All information contained herein is provided  for the purpose of discussion and peer review only and should not be construed as formal legal advice. The authors disclaim any and all liability resulting from reliance upon such information. You are strongly encouraged to seek professional legal advice before relying upon any of the information contained herein. Legal advice should be sought directly from a properly retained lawyer or attorney. 

WARNING: Please do not attempt to use any text, image, or video that you see on this site in Court. These comments, images, and videos are NOT EVIDENCE. The Courts will need to hear evidence from a properly qualified expert. The author is not a scientist. The author is not an expert. These pages exist to promote discussion among defence lawyers.

 

Intoxilyzer®  is a registered trademark of CMI, Inc. The Intoxilyzer® 5000C is an "approved instrument" in Canada.
Breathalyzer® is a registered trademark of Draeger Safety, Inc., Breathalyzer Division. The owner of the trademark is Robert F. Borkenstein and Draeger Safety, Inc. has leased the exclusive rights of use from him. The Breathalyzer® 900 and Breathalyzer® 900A were "approved instruments" in Canada.
DrugTest® 5000 is also a registered trademark of Draeger Safety, Inc.. DrugTest® 5000 is "approved drug screening equipment" in Canada.
Alcotest® is a registered trademark of Draeger Safety, Inc. The Alcotest® 7410 GLC and 6810 are each an "approved screening device" in Canada.
Datamaster®  is a registered trademark of National Patent Analytical Systems, Inc.  The BAC Datamaster® C  is an "approved instrument" in Canada.